Eevia Health Plc received a 742 KSEK / 64 KEUR sales order for a Bilberry extract product
Eevia Health Plc’s (”Eevia” or ”The Company”) has received a 64 KEUR sales order from French distributor Natural Ingredients, for Feno-Myrtillus 36 organic, an organically certified bilberry extract.
Natural Ingredients is a French distributor company located near Angers, in the Loire Valley. Their specialty is natural and functional ingredients for the food supplement industry. Natural Ingredients' reputation for delivering high-quality natural products aligns perfectly with Eevia Health's mission to promote health and well-being using sustainable arctic botanical extracts.
The sales value to Eevia of this new order is just above kEUR 64. The product is Eevia’s branded ingredient Feno-Myrtillus® 36 Organic, which is a highly concentrated and organically certified bilberry extract with 36% anthocyanins.
Bilberry anthocyanins have shown clinical benefits for humans related to eye health and metabolic conditions, among other benefits. Eevia Health released a white paper this week on this product line.
The order is expected to be followed by further repeat orders in the future. Eevia Health's commitment to sustainable practices, traceability, and stringent quality control enables Natural Ingredients to confidently distribute these ingredients while adhering to the values and expectations.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com or investor@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.
